Progenics Pharmaceuticals, Inc. (13) | Stock Agreements (2)
- Description of Capital Stock (Filed With SEC on March 13, 2020)
- Amendment to the Stock Purchase and Sale Agreement, dated May 9, 2019, by and between Progenics Pharmaceuticals, Inc., Molecular Insight Pharmaceuticals, Inc., and Highland... (Filed With SEC on May 14, 2019)
